Upcoming Sessions – Bridging HIV & SUD: Innovations in the Field Webinar Series
Posted July 3, 2025Webinar Series
NAHEWD’s Bridging HIV & SUD: Innovations in the Field
Updates on Long-Acting Injectable Buprenorphine for People with Opioid Use Disorder will occur on Friday, July 11, at 12 pm ET. Presented by Sarah Rosenwohl-Mack, MD, MPH, AAHIVS, the speaker will review current guidelines and evidence for long-acting injectable (LAI) buprenorphine in people with opioid use disorder (OUD), as well as emerging evidence and best practices around direct-to-inject buprenorphine initiation. Register for the session here.
Tackling Stigma and Providing Quality Care around Substance Use among Older Adults with HIV will occur on Friday, August 1, at 12 pm ET. Presented by Sid Puri, MD, this presentation will explore substance use among older adults living with HIV, emphasizing the unique risk factors they face and the impact of stigma on care. It will introduce practical tools such as validated screeners, motivational interviewing, and harm reduction strategies to foster compassionate, person-centered care. Through a case study and evidence-based approaches, participants will learn how to build trust, reduce substance-related harms, and support long-term wellness in this vulnerable population. Register for the session here.
Harm Reduction Approaches to Substance Use Disorder Treatment for Non-Abstinent Patients will occur on Friday, September 12, at 12 pm ET. Presented by Sarah Axelrath, MD, FASAM, the presenter will discuss best practices in the treatment of non-abstinent patients with opioid and stimulant use disorders. Based on the American Society for Addiction Medicine guidelines and clinical experience, these best practices can be implemented in any primary care or specialty addiction treatment setting. Register for the session here.
